Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: R/S vs. Share-buyback vs. Doing nothing

So, if we´re getting a reverse split, we´re going to get a smaller number of shares and therefore a smaller leverage ........... in the best case.....................

As the Authorized is NOT reduced in the event of a r/s, how will that give a smaller leverage?

Share
New Message
Please login to post a reply